Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

[Strengthening preventive potential in care counseling].

Angele S, Calero C.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Mar;62(3):320-328. doi: 10.1007/s00103-019-02906-0. Review. German.

PMID:
30788539
2.
3.

Expression of ATM, p53, and the MRE11-Rad50-NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast.

Angèle S, Jones C, Reis Filho JS, Fulford LG, Treilleux I, Lakhani SR, Hall J.

J Clin Pathol. 2004 Nov;57(11):1179-84.

4.

ATM polymorphisms as risk factors for prostate cancer development.

Angèle S, Falconer A, Edwards SM, Dörk T, Bremer M, Moullan N, Chapot B, Muir K, Houlston R, Norman AR, Bullock S, Hope Q, Meitz J, Dearnaley D, Dowe A, Southgate C, Ardern-Jones A, Easton DF, Eeles RA, Hall J.

Br J Cancer. 2004 Aug 16;91(4):783-7.

5.

Functional consequences of ATM sequence variants for chromosomal radiosensitivity.

Gutiérrez-Enríquez S, Fernet M, Dörk T, Bremer M, Lauge A, Stoppa-Lyonnet D, Moullan N, Angèle S, Hall J.

Genes Chromosomes Cancer. 2004 Jun;40(2):109-19.

PMID:
15101044
6.

ATM protein overexpression in prostate tumors: possible role in telomere maintenance.

Angèle S, Falconer A, Foster CS, Taniere P, Eeles RA, Hall J.

Am J Clin Pathol. 2004 Feb;121(2):231-6.

PMID:
14983937
7.

ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.

Angèle S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gérard JP, Hall J.

Cancer Res. 2003 Dec 15;63(24):8717-25.

8.

Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy.

Moullan N, Cox DG, Angèle S, Romestaing P, Gérard JP, Hall J.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1168-74.

9.

Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas.

Angèle S, Treilleux I, Brémond A, Tanière P, Hall J.

Histopathology. 2003 Oct;43(4):347-53.

PMID:
14511253
10.

Idiopathic and radiation-induced ocular telangiectasia: the involvement of the ATM gene.

Mauget-Faÿsse M, Vuillaume M, Quaranta M, Moullan N, Angèle S, Friesen MD, Hall J.

Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3257-62.

PMID:
12882767
11.

Variation in radiation-induced apoptosis in ataxia telangiectasia lymphoblastoid cell lines.

Fernet M, Angele S, Dörk T, Hall J.

Int J Radiat Biol. 2003 Mar;79(3):193-202.

PMID:
12745884
12.

[National development of health targets in Germany--the health targets.de Forum].

Angele S, Philippi B.

Z Arztl Fortbild Qualitatssich. 2003 Feb;97(1):59-65. German.

PMID:
12669691
13.

Phenotypic cellular characterization of an ataxia telangiectasia patient carrying a causal homozygous missense mutation.

Angèle S, Laugé A, Fernet M, Moullan N, Beauvais P, Couturier J, Stoppa-Lyonnet D, Hall J.

Hum Mutat. 2003 Feb;21(2):169-70.

PMID:
12552566
14.

[What do we know about ATM protein expression in breast tissue?].

Angèle S, Tanière P, Hall J.

Bull Cancer. 2001 Jul;88(7):671-5. Review. French.

15.

Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas.

Angèle S, Treilleux I, Tanière P, Martel-Planche G, Vuillaume M, Bailly C, Brémond A, Montesano R, Hall J.

Clin Cancer Res. 2000 Sep;6(9):3536-44.

16.

The ATM gene and breast cancer: is it really a risk factor?

Angèle S, Hall J.

Mutat Res. 2000 Apr;462(2-3):167-78. Review.

PMID:
10767628
17.

Radiation, DNA damage and cancer.

Hall J, Angèle S.

Mol Med Today. 1999 Apr;5(4):157-64. Review.

PMID:
10203748

Supplemental Content

Loading ...
Support Center